ESOC-WSO 2020 - DEMO

ABOUT THIS WEBINAR
We are delighted to present you with five of the highest-rated research works which are part of our scientific programme
AGENDA
  • 13:00 – 13:05 - Opening remarks
  • 13:05 – 13:20 - Trial 1: Efficacy of Fluoxetine: A Randomized Controlled Trial in Stroke (Effects) – Erik Lundström (Sweden)
  • 13:20 – 13:35 - Trial 2: Assessment of Fluoxetine in Stroke Recovery (Affinity): Results of a Double-blind, Placebo-controlled, Randomised Trial – Graeme Hankey (Australia)
  • 13:35 – 13:50 - Trial 3: A Randomized Trial of Direct Endovascular Thrombectomy Versus Thrombectomy Preceded by Intravenous Alteplase in Acute Ischemic Stroke – Jianmin Liu (China)
  • 13:50 – 14:05 - Trial 4: The Basilar Artery International Collaboration Study (Basics): A Randomized Controlled Trial of Endovascular Therapy in Basilar Artery Occlusion – Wouter Schonewille (Netherlands)
  • 14:05 – 14:20 - Trial 5: Ascot Trial: The Effect of Randomisation to Atorvastatin or Placebo, and Amlodipine-based or Beta-blocker-based Regime on 20-year Incidence of Stroke or Dementia – William Whiteley (UK)
  • 14:20 – 14:25 - Closing remarks
ADDITIONAL INFO
  • When: Vienna
  • Duration: 2 hours
  • Price: Free
  • Language: English
  • Who can attend? Anyone with the event link can attend
  • Dial-in available? (listen only): Not available.
ATTENDED (13)
  • 1588823057-d631ef19ee76c71c
  • R
  • G
  • G
  • G
  • G
  • M
  • D
  • G
  • B
  • E
  • K
  • G
Also by Kenes